Zika virus vaccine
Zika virus vaccine is a vaccine that is currently under development to prevent Zika virus infection. Zika virus is a mosquito-borne flavivirus that was first identified in Uganda in 1947 in monkeys. It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania. Transmission of Zika virus can occur through a mosquito bite, from a pregnant woman to her fetus, through sexual contact, and through blood transfusion.
Development
The development of a Zika virus vaccine began after the 2015–16 Zika virus epidemic, which caused a significant increase in cases of microcephaly and Guillain–Barré syndrome in areas where Zika virus is endemic. Several different types of vaccines are being developed, including DNA vaccines, RNA vaccines, and inactivated vaccines. As of 2021, no vaccine has been approved for general use, but several are in clinical trials.
DNA Vaccines
DNA vaccines work by inserting DNA coding for a particular antigen into the body, which then produces the antigen and stimulates an immune response. Several DNA vaccines for Zika virus are in development, including VRC5283 and VRC5288, which are being developed by the Vaccine Research Center at the National Institutes of Health.
RNA Vaccines
RNA vaccines work in a similar way to DNA vaccines, but use RNA instead of DNA. An RNA vaccine for Zika virus, called mRNA-1325, is being developed by Moderna.
Inactivated Vaccines
Inactivated vaccines work by using a killed or inactivated version of the virus to stimulate an immune response. An inactivated vaccine for Zika virus, called ZPIV, is being developed by the Walter Reed Army Institute of Research.
Clinical Trials
Several Zika virus vaccines are currently in clinical trials. These trials are necessary to ensure that the vaccines are safe and effective before they can be approved for general use.
See Also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

